Geron Corporation's IPO

Geron Corporation raised a round of funding on , . Investors include Public.

Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The company is advancing …

Articles about Geron Corporation's IPO: